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Pasteurella multocida is the causative agent of fowl cholera in birds. In a previous study using signature-
tagged mutagenesis, we identified a mutant, AL251, which was attenuated for virulence in mice and in the
natural chicken host. Sequence analysis indicated that AL251 had an insertional inactivation of the gene
waaQPM, encoding a putative heptosyl transferase, required for the addition of heptose to lipopolysaccharide
(LPS) (M. Harper, J. D. Boyce, I. W. Wilkie, and B. Adler, Infect. Immun. 71:5440–5446, 2003). In the present
study, using mass spectrometry and nuclear magnetic resonance, we have confirmed the identity of the enzyme
encoded by waaQPM as a heptosyl transferase III and demonstrated that the predominant LPS glycoforms
isolated from this mutant are severely truncated. Complementation experiments demonstrated that providing
a functional waaQPM gene in trans can restore both the LPS to its full length and growth in mice to wild-type
levels. Furthermore, we have shown that mutant AL251 is unable to cause fowl cholera in chickens and that
the attenuation observed is not due to increased serum sensitivity.
Pasteurella multocida is an encapsulated, gram-negative coc-
cobacillus and is the causative agent of a wide range of animal
diseases including avian fowl cholera. Several P. multocida
virulence factors have previously been identified, including the
capsule in serogroups A and B (4, 6), PMT toxin in strains
causing atrophic rhinitis in pigs (18), putative filamentous hem-
agglutinins PfhB1 and PfhB2 (19), and several iron acquisition
proteins such as TonB, ExbD and ExbB (3, 19, 27).
During infections by gram-negative bacteria, the presence of
lipopolysaccharide (LPS) stimulates the innate immune system
whereby the inflammatory response plays a critical role in
helping to clear the bacteria and prevent infection. This initial
response to gram-negative bacteria can be elicited by a number
of bacterial components, the most potent being lipid A, a
component of the core structure of LPS. If the inflammatory
response in the host is unable to clear the bacteria and the
infection is allowed to proceed, the presence of large amounts
of systemic LPS can result in endotoxic shock, in which an
overproduction of inflammatory mediators causes damage to
tissues, septic shock, organ failure, and death (31).
LPS is considered to play an important role in the patho-
genesis of disease due to P. multocida. Recently it has been
shown that LPS from P. multocida assists in adhesion to neu-
trophils and transmigration through endothelial cells (20).
However, there are conflicting reports about the endotoxic
properties of LPS isolated from P. multocida. LPS isolated
from a serotype B:2 strain was shown to be endotoxic, and
intravenously administered LPS could reproduce clinical signs
of hemorrhagic septicemia in buffalo (24). However, turkey
poults were found to be relatively resistant to the lethal effects
of LPS isolated from serogroup A strains of P. multocida,
although the inflammatory response and microscopic hepatic
lesions were similar to those observed in mammalian hosts (29,
34). In contrast, chicken embryos and mice were found to be
highly susceptible to the toxic effects of P. multocida LPS (21).
It is clear that the LPS of P. multocida stimulates humoral
immunity, and it is considered to be a protective antigen. P.
multocida strains are classified into Heddleston serotypes
based on the antibody responses to LPS, while antibodies
raised against heat-killed P. multocida vaccines are directed
primarily against LPS and protect the host against strains
within the same serotype (5). Early studies demonstrated that
LPS purified using the Westphal method and injected into
mice and rabbits resulted in a poor antibody response and no
protection against P. multocida infection. In contrast, LPS in-
jected into chickens induced a good antibody response which
passively protected recipients against disease (33). Monoclonal
antibodies raised against the LPS from a serotype A strain
were shown to be bactericidal and to completely protect mice
against homologous challenge (43). In addition, an opsonic
monoclonal antibody against LPS from a serotype B strain of
P. multocida was shown to partially protect mice against P.
multocida infection (32).
A modified LPS structure clearly affects the viability of P.
multocida in vivo. Recently in our laboratory, we identified
three strongly attenuated mutants that each had a single trans-
poson insertion in the pm1294 gene (designated waaQPM) (22).
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This gene is predicted to encode a heptosyltransferase, based
on 72% amino acid similarity to the heptosyltransferase III
from Haemophilus ducreyi, a member of the Pasteurellaceae
family (17). Furthermore, a P. multocida galE mutant has been
constructed previously and was attenuated in mice (16). galE
encodes an enzyme required for the epimerization of UDP-
glucose to UDP-galactose prior to LPS assembly, and this
mutant probably expresses an altered LPS, although no struc-
tural analysis of the LPS was reported (16).
The sugar composition of LPS isolated from two serotype A
strains of P. multocida was analyzed previously, and a partial
structure has been proposed that included the identification of
a triheptose unit linked to a 2-keto-3-deoxyoctulosonic acid
(KDO) residue (12–14). In this report we present the core
structure of LPS from a highly virulent P. multocida serotype
A:1 strain, VP161, that causes fowl cholera and compare it with
the structure of LPS from a transposon mutant deficient in
heptosyltransferase III. We also present virulence data that
demonstrate a significant role for LPS in P. multocida disease
progression.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, and growth conditions. The bacterial
strains and plasmids used in this study are listed in Table 1. Escherichia coli was
grown routinely in Luria-Bertani broth. P. multocida strains were grown in either
brain heart infusion (BHI) broth or nutrient broth (NB) supplemented with 3%
yeast extract (Oxoid, Basingstoke, United Kingdom). Solid media were obtained
by the addition of 1.5% agar. When required, the media were supplemented with
tetracycline at 2.5 g/ml. For structural studies, P. multocida strains VP161 and
AL251 were grown in a 28-liter fermentor containing 24-liters of BHI broth for
18 h at 37°C with 20% dissolved-oxygen saturation. The cells were killed by
addition of phenol to 2%, and 3 h after the phenol addition, 1 g of hyaluronidase
(Roche Chemicals) was added; the mixture was stirred for 1 h before cells were
harvested by using a Sharples continuous-flow centrifuge.
Transposon stability studies. P. multocida AL251 was grown in 10 ml of NB at
37°C with shaking. After approximately 10, 34, and 58 generations, samples of
the culture were taken, diluted appropriately, and plated onto NB agar. After
overnight incubation, 100 colonies were patched onto NB agar with tetracycline
and incubated overnight at 37°C. Transposon loss was expressed as the percent-
age of tetracycline-sensitive colonies.
SDS-PAGE and silver staining. LPS was analyzed with a Bio-Rad mini protein
gel apparatus, using sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) as described previously (25). LPS was then visualized by silver
staining (40).
DNA manipulations. Restriction digests, ligations, and PCR amplifications
were performed as specified by the manufacturers, using enzymes obtained from
NEB (Beverley, Mass.) or Roche Diagnostics GmbH (Mannheim, Germany).
Plasmid DNA was prepared using alkaline lysis (2) and purified using Qiagen
columns (Qiagen GmbH, Hilden, Germany) or by polyethylene glycol precipi-
tation (1). Genomic DNA was prepared using the cetyltrimethylammonium
bromide (CTAB) method (1). PCR amplification of DNA was performed using
Taq DNA polymerase or the Expand High Fidelity PCR system (Roche Diag-
nostics), and the DNA was purified using the Qiagen PCR purification kit. The
oligonucleotides used in this study are listed in Table 1. The DNA sequence was
determined on a model 373A DNA sequencing system (Applied Biosystems) and
analyzed with Sequencher version 3.1.1 (GeneCodes, Ann Arbor, Mich.).
In trans complementation of waaQPM. The complete waaQPM gene was am-
plified from P. multocida VP161 genomic DNA using oligonucleotides BAP2146
and BAP2147 (Table 1). The amplified 1.1-kb DNA fragment was ligated to SalI-
and BamHI-digested vector pAL99 (Table 1), such that transcription was driven
by the P. multocida tpiA promoter. E. coli transformants were screened for the
presence of the correct plasmid, and one, designated pAL170, was used to
transform P. multocida AL251, generating strain AL298. As a control, the pAL99
vector was transformed separately into AL251, generating strain AL438 (Table
1).
Competitive growth assays. Competitive growth assays were performed as
described previously (22) and were used to quantify the relative growth rates of
the P. multocida LPS mutant AL251 and the complemented mutant AL298. The
competitive index (CI) was determined by dividing the percentage of tetracy-
cline-resistant colonies obtained from the output culture (in vitro or in vivo) by
the percentage of tetracycline-resistant colonies obtained from the input culture.
The relative competitive index (rCI), which measures the difference between
growth in vivo and growth in vitro, was determined by dividing the in vivo CI by
the in vitro CI. Mutants were identified as attenuated if the rCI value was
significantly less than 1.0 as determined by statistical analysis using the one sided
z test (P  0.05).
Virulence trials. Groups of 10 commercially obtained Leghorn-cross chickens
aged 12 weeks were infected with P. multocida VP161 or AL251 at two different
doses by injection of 100 l into the breast muscle. Blood samples were obtained
at various time points after infection with AL251, and the birds deemed incapa-
ble of survival were euthanized in accordance with animal ethics requirements.
TABLE 1. Bacterial strains, plasmids and oligonucleotides used in this study
Strain, plasmid or
oligonucleotide Relevant description Source or reference
Strains
P. multocida
VP161 Serotype A:1, Vietnamese isolate from chickens 44
AL251 VP161 Tn916EC waaQPM mutant 22
AL298 AL251 with plasmid pAL170 This study
AL438 AL251 with plasmid pAL99 This study
E. coli
DH5 deoR endA1 gyrA96 hsdR17(rk
 mk
) recA1 relA1 supE44 thi-1
(lacZYA-argFV169) 80lacZ M15, F
Bethesda Research Laboratories
Plasmids
pPBA1100 P. multocida/E. coli shuttle vector 23
pAL99 240-bp EcoRI fragment containing P. multocida tpiA promoter
region cloned into pPBA1100 EcoRI site
This study
pAL170 pAL99 containing waaQPM gene This study
Oligonucleotides
BAP2146 Forward primer for waaQPM amplification; has BamHI site for
cloning; GAGTAGGATCCTGAAACATGTTCCC
This study
BAP2147 Reverse primer for waaQPM amplification; has SalI site for cloning;
GGTTGGGTCGACCAAGCCACATTACTG
This study
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Blood samples were diluted twofold in BHI broth containing heparin and plated
onto BHI plates. P. multocida colonies isolated from the blood were patched
onto NB agar and NB agar with tetracycline.
Serum sensitivity assays. The sensitivity of P. multocida and E. coli to fresh
chicken serum was determined as described previously (6).
Purification of LPS. P. multocida cells (210 g [wet weight] of VP161; 254 g [wet
weight] of AL251) were freeze-dried, yielding 56 g of VP161 and 52 g of AL251.
Freeze-dried cells were washed with organic solvents to remove lipids and other
lipophilic components in order to enhance the efficiency of the LPS extraction
(26). Washed cells (42 g of VP161; 50 g of AL251) were extracted by the
hot-phenol–water method (42), and the aqueous phases were combined and
dialyzed against running water for 48 h. The retentate was freeze-dried, made up
to a 2% solution in water, and treated with DNase and RNase at 37°C for 4 h and
then with proteinase K at 37°C for 4 h. Small peptides were removed by dialysis.
After a freeze-drying step, the retentate was made up to a 2% solution in water
and centrifuged at 8,000  g for 15 min, and the supernatant was further
centrifuged at 100,000  g for 5 h. The pellet, containing purified LPS, was
redissolved and freeze-dried. The core oligosaccharide (OS) was isolated by
treating the purified LPS with 1% acetic acid (10 mg/ml) at 100°C for 1.5 h, with
subsequent removal of the insoluble lipid A by centrifugation (5,000  g).
Analytical methods. Sugars were identified on the basis of their alditol acetate
derivatives (35) by gas-liquid chromatography and mass spectrometry (GLC-
MS). LPS was hydrolyzed for 4 h using 4 M trifluoroacetic acid at 100°C, reduced
overnight with NaBD4 in H2O, and then acetylated with acetic anhydride at
100°C for 2 h using residual sodium acetate as the catalyst. The GLC-MS
apparatus was equipped with a 30-m DB-17 capillary column (180 to 260°C at
3.5°C/min), and MS was performed in the electron impact mode on a Varian
Saturn II mass spectrometer. Methylation analysis was carried out by the NaOH-
dimethyl sulfoxide-methyl iodide procedure (7) and analyzed by GLC-MS as
above.
MS analysis. Capillary electrophoresis electrospray ionization MS (CE-ESI-
MS) was performed on a crystal model 310 capillary electrophoresis (CE) in-
strument (AYI Unicam) coupled to an API 3000 mass spectrometer (Perkin-
Elmer/Sciex) via a microIonspray interface (9). A sheath solution (isopropanol-
methanol, 2:1 [vol/vol]) was delivered at a flow rate of 1 l/min to a low-dead-
volume tee (250-m inner diameter [Chromatographic Specialties]). All aqueous
solutions were filtered through a 0.45-m pore-size filter (Millipore) before use.
Nuclear magnetic resonance. Nuclear magnetic resonance (NMR) spectra
were acquired on a Varian Inova 500 MHz spectrometer using a 3-mm triple-
resonance (1H, 13C, and 31P) probe. The lyophilized sugar sample was dissolved
in 140 l of 99% D2O. The experiments were performed at 25°C with suppres-
sion of the HOD (deuterated H2O) signal at 4.78 ppm. The methyl resonance of
acetone was used as an internal or external reference at 2.225 ppm for 1H spectra
and 31.07 ppm for 13C spectra. Standard homo- and heteronuclear correlated
two-dimensional pulse sequences from Varian, COSY, TOCSY, NOESY,
13C-1H HSQC, 13C-1H HSQC-TOCSY, and 13C-1H HMBC were used for gen-
eral assignments.
RESULTS
An attenuated P. multocida mutant produces a truncated
LPS that is restored to full-length LPS by complementation
with a functional waaQPM gene. We have previously used sig-
nature-tagged mutagenesis (STM) to identify mutants attenu-
ated for growth in mice and chickens (22). During this previous
analysis, a mutant was identified (designated AL251) that grew
equally well as the wild type in vitro (mean CI 	 0.96) but was
attenuated in both chickens (mean CI 	 0.01) and mice (mean
CI 	 0.59). Sequence analysis of the mutant revealed a single
transposon insertion within the waaQPM gene that is predicted
to encode a heptosyltransferase, a glycosyltransferase respon-
sible for the addition of heptose to LPS (17,22).
We compared the LPS profile of AL251 with that of its
wild-type parent, VP161, and the complemented mutant,
AL298, using SDS-PAGE followed by silver staining. The LPS
from AL251 migrated further within the gel compared to wild-
type LPS, indicating that the LPS produced by the mutant was
significantly truncated (Fig. 1A). Furthermore, the LPS profile
of the complemented mutant AL298 was identical to that ob-
served for the wild type, indicating that complementation of
the AL251 mutant with an intact waaQPM gene was able to
restore the synthesis of wild-type LPS (Fig. 1A).
Complementation of AL251 with waaQPM also restores in
vivo growth to wild-type levels. Since complementation of
AL251 with waaQPM restored production of wild-type LPS
levels, we wanted to determine if complementing the inacti-
vated waaQPM also restored the mutant AL251 to wild-type
levels of growth in vivo. Initial studies with the complemented
mutant AL298 indicated that there was significant loss of the
complementing plasmid pAL170 once antibiotic selection for
the plasmid was removed (44% retention after 6 h). For this
reason, mice were chosen instead of chickens for the compet-
itive growth assay, since previous studies had demonstrated
that the infection time required to harvest bacteria from mice
was only 6 h compared with more than 12 h for infections in
chickens (22). Three mice were injected with an equal mix of
VP161 and the complemented strain AL298. As controls, two
mice were injected with an equal mix of wild-type VP161 and
the control strain AL438 (AL251 with the pAL99 vector). The
complemented mutant AL298 was able to compete equally
with wild-type VP161, with an average rCI value of 1.0, while
the control strain AL438 had an average rCI value of 0.57 (P	
0.03), similar to the rCI values previously reported for AL251
in mice (22). These results demonstrate that waaQPM is re-
quired both for production of full-length LPS and for normal
growth during infection.
The P. multocida waaQPM mutant is unable to cause disease
in chickens. We had shown previously that strain AL251 dis-
FIG. 1. Analysis of P. multocida LPS by SDS-PAGE and silver
staining of whole-cell lysates. (A) Comparison of P. multocida LPS
profiles from wild-type VP161 (lane 1), heptosyltransferase mutant
AL251 (lane 2), control strain AL438 (AL251 containing vector plas-
mid pAL99) (lane 3), and the complemented mutant strain AL298
(lane 4). (B) Comparison of LPS profiles of P. multocida heptosyl-
transferase mutant AL251 (lane 1), wild-type VP161 (lane 2), and P.
multocida wild-type revertants isolated from three different chickens
inoculated with AL251 (lanes 3 to 5).
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played a profoundly reduced growth rate in chickens (22);
therefore, we wished to determine whether the mutant was still
capable of causing disease in these hosts. Chickens were chal-
lenged with either VP161 or AL251 at two different doses
(Table 2). All of the chickens challenged with wild-type VP161
died within 20 h. In contrast, most chickens challenged with
AL251 remained well over the first 20 h but within 4 days all of
the chickens inoculated with AL251, irrespective of dose, suc-
cumbed to fowl cholera infection. P. multocida was isolated
from the blood of AL251-infected chickens in the late or ter-
minal stages of the disease, and it was found that all of the
isolated P. multocida colonies were tetracycline sensitive, indi-
cating that the transposon was no longer present in the bacte-
ria. Sequence analysis of waaQPM from the recovered colonies
indicated that in all cases the transposon had excised, thereby
reconstituting a functional waaQPM gene. Interestingly, for all
but one isolate, the sequence analysis also revealed the pres-
ence of nucleotide substitutions at the point of transposon
excision, resulting in two amino acid changes within waaQPM
(amino acids 88 and 89; Ser to Leu and Asp to Cys, respec-
tively). These amino acid changes did not affect the function of
waaQPM, since the LPS profiles of the P. multocida isolates
recovered from the chickens challenged with AL251 were all
identical to those for the wild type (Fig. 1B). Taken together,
these results indicate that the later onset of fowl cholera ob-
served in the chickens inoculated with AL251 was due entirely
to wild-type revertants of AL251 and that strains with an in-
activated waaQPM gene are therefore incapable of causing
disease.
Attenuation of the waaQPM mutant in chickens is not due to
increased sensitivity to chicken serum. To determine the rel-
ative sensitivity of the wild-type P. multocida strain VP161 and
the LPS mutant AL251 to complement-mediated killing, mid-
log-phase cells of each strain and a control strain, E. coli
DH5, were incubated in either normal or heat-treated
chicken serum for 3 h. Wild-type P. multocida strain VP161
was able to grow at the same rate in both the heated and the
unheated serum, indicating that it is fully serum resistant as
previously reported for other P. multocida serotype A strains
(11). The bactericidal activity of the chicken serum was con-
firmed using the E. coli control strain, which multiplied 19-fold
in heat-treated serum whereas its viability was reduced approx-
imately 9-fold in untreated serum. Interestingly, for the AL251
mutant, no difference in growth was observed between the
heat-treated and normal serum, with approximately a 160-fold
increase in growth in the heat-treated serum and an identical
growth rate in the normal serum. These results indicate that
the attenuation observed for the LPS mutant in chickens was
not due to increased sensitivity to complement.
Structural analysis of the LPS from P. multocida VP161 and
AL251. Sugar analysis of the LPS from the parent strain VP161
revealed glucose (Glc), galactose (Gal), N-acetylglucosamine
(GlcNAc), and L-glycero-D-manno-heptose (LD-Hep) in the ra-
tio of 2:1:1:3. In contrast, the LPS from mutant strain AL251
revealed only Glc and LD-Hep in the ratio of 1:3 with traces of
Gal and GlcNAc. It is possible that GlcNAc could be contrib-
uted by residual amounts of the hyaluronic acid capsule known
for this serogroup in addition to the anticipated two residues in
the lipid A region of each LPS molecule. CE-ESI-MS analyses
of the core OS sample derived from the parent VP161 LPS
revealed a simple mass spectrum (Fig. 2a) corresponding to
two glycoforms with masses of 1,805 and 1,967 Da, the smaller
glycoform being consistent with a composition of 2PCho 
3Hex  4Hep  KDO, where KDO is the unique LPS sugar
2-keto-3-deoxyoctulosonic acid and PCho is the phosphate
moiety phosphocholine. The larger glycoform contains an ad-
ditional hexose species (Table 3; Fig. 2a). Consistent with SDS-
PAGE analysis of the mutant AL251 LPS, CE-ESI-MS analy-
ses of the core OS sample derived from the mutant AL251 LPS
revealed a simple mass spectrum of a highly truncated mole-
cule with a mass of 605 Da (Fig. 2b). This mass corresponds to
a composition of 2Hep  KDO. A larger glycoform was ob-
FIG. 2. Negative-ion CE-ESI-MS of P. multocida core OS. (a)
Doubly charged region of core OS from parent strain VP161; (b) singly
charged region of core OS from mutant strain AL251.
TABLE 2. Virulence of VP161 and AL251 in groups of 10 chickens
Strain Dose (CFU)
Mean time to
death (range)
(h)
VP161 1.5  102 20 (NDa)
1.5  103 20 (ND)
AL251 70 65 (33–120)
7  102 30 (23–42)
a ND, not determined.
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served, consistent with the presence of an additional hexose
residue (767 Da). Trace amounts of a more extended glyco-
form of 1,448 Da (PCho  3Hep  3Hex  KDO) were
observed, but no glycoforms were observed that contained the
full parental complement of four Hep residues (Table 3). To
characterize completely the nature of the truncation in the
core OS of the mutant strain, 1H-NMR experiments were
performed on the parent- and mutant-derived core OS. Since
MS data had suggested that a Hep residue was missing in the
mutant OS and amino acid homology comparisons had sug-
gested that WaaQPM was a heptosyltransferase, close attention
was paid to the resonances from the heptose residues of the
molecule. Examination of the 1H-NMR spectra revealed some
heterogeneity for the heptose residues closest to KDO, as is
often observed for core oligosaccharides due to rearrangement
of the KDO residue under the acidic hydrolysis conditions
used to obtain the core OS (Fig. 3). For the core OS derived
from the parent strain, chemical shifts for the Hep II anomeric
proton were identified at 
5.7 ppm, consistent with 2-substi-
tution of this residue (Fig. 3a) (9). However, in the AL251
mutant OS 1H-NMR spectrum (Fig. 3b), the anomeric reso-
nance for the Hep II residue had shifted up-field about 0.5
ppm, consistent with this residue no longer being 2-substituted.
The Hep II residue is now a terminal moiety, as we have
observed previously for a Haemophilus somnus strain, and the
chemical shifts to the H-4 resonance were consistent with this
assignment (8). Definitive evidence for the structural nature of
the mutation was obtained from two-dimensional NOESY ex-
periments (Fig. 4). Characteristic nuclear Overhauser effects
(NOEs) were observed for VP161 core OS between the Hep
III and Hep II anomeric protons that are diagnostic for the
-1-2 linkage between the Hep III and Hep II residues (Fig. 4)
(9). The NOESY spectrum of the AL251 mutant core OS
confirmed the lack of 2-substitution of Hep II as the charac-
teristic NOEs described above were absent, confirming that the
FIG. 3. Region of the 1H-NMR spectrum of the core OS derived
from the LPS of P. multocida parent strain VP161 (a) and P. multocida
mutant strain AL251 (b). The spectra were recorded at 25°C and
referenced against internal acetone at 2.225 ppm.
FIG. 4. Region of the NOESY spectrum of P. multocida VP161
core OS. NOE connectivities are as indicated. (Inset), Structure of the
inner-core OS from VP161. The spectrum was recorded at 25°C and
referenced against internal acetone at 2.225 ppm.
TABLE 3. Negative-ion CE-MS data and proposed compositions for core OS from P. multocida strains VP161 (parent) and AL251 (mutant)a
Strain [M  H] [M  H]2
Observed
mass of
molecular ion
Calculated
mass of
molecular Ion
Relative
intensity Proposed composition
VP161 1,804.4 901.8 1,805.6 1,805.4 0.2 2PCho  4Hep  3Hex  aKDOb
1,822.4 910.9 1,823.1 1,823.4 1.0 2PCho  4Hep  3Hex  KDO
921.8 1,845.1 1,845.4 0.3 2PCho  4Hep  3Hex  KDO  Na
1,966.3 982.9 1,967.8 1,967.6 0.9 2PCho  4Hep  4Hex  aKDO
1,988.4 993.9 1,989.1 1,989.6 0.3 2PCho  4Hep  4Hex  aKDO  Na
AL251 603.5 604.5 604.5 1.0 2Hep  aKDO
621.5 622.5 622.5 0.9 2Hep  KDO
765.5 766.5 766.7 0.8 Hex  2Hep  aKDO
1,447.5 1,448.5 1,448.2 0.1 PCho  3Hep  3Hex  aKDO
a Average mass units were used for calculation of molecular weight based on proposed composition as follows: Hex, 162.15; Hep, 192.17; Kdo, 220.18; PCho, 165.05.
Relative intensity is expressed as relative height of either doubly or singly charged ions.
b aKDO, anhydro-KDO derivative.
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Hep III residue is no longer present in the mutant OS. Chem-
ical shift and NOE data for the Hep II and Hep III residues for
the parent OS and Hep II residue for the mutant OS are
summarized in Table 4. Structural techniques have therefore
demonstrated that the effect on the LPS structure of mutating
gene waaQPM is to preclude the addition of Hep III to Hep II
(Fig. 5), and this function is consistent with strong similarity of
the encoded protein to known heptosyltransferases.
DISCUSSION
The P. multocida LPS mutant AL251, first identified using
STM in mice and chickens, was shown to have a transposon
insertion in a predicted heptosyltransferase gene, waaQPM, and
was significantly attenuated in chickens and mice (22). Silver-
stained polyacrylamide gels of cell lysates from wild-type
VP161 and AL251 showed that the LPS from the mutant was
significantly truncated (Fig. 1A), consistent with waaQPM en-
coding a heptosyltransferase responsible for the addition of a
heptose molecule in the core region of the LPS structure.
Analysis of the P. multocida Pm70 genome revealed that the
waaQPM gene was probably transcribed independently and
therefore the truncated LPS structure and reduced growth in
vivo in chickens and mice were due directly to the inactivation
of waaQPM and not to polar effects on downstream genes (27).
This was confirmed by complementation, since the introduc-
tion of a wild-type waaQPM gene in trans restored both the LPS
structure (Fig. 1A) and wild-type levels of growth in mice.
Virulence trials using the LPS mutant AL251 in chickens
resulted in a delayed onset of fowl cholera symptoms (Table 2),
and P. multocida strains isolated from chickens with disease
symptoms were tetracycline sensitive, indicating that they no
longer carried the transposon. Nucleotide sequence data ob-
tained from P. multocida DNA isolated from infected birds
confirmed that the waaQPM gene was intact and, in most cases,
had nucleotide base changes at the point where the transposon
had previously been inserted, resulting in two amino acid
changes. The LPS from the P. multocida isolates recovered
from the chickens challenged with AL251 showed that they
produced wild-type LPS, confirming that the waaQPM gene was
functional despite the amino acid changes (Fig. 1B). Moreover,
these results suggest that serine and aspartate, at amino acid
positions 88 and 89, respectively, in WaaQPM, are not essential
for full enzyme activity since nonconservative changes at these
positions did not prevent the formation of full-length LPS.
Taken together, these data indicate that the infection observed
in chickens inoculated with AL251 was due only to revertant
strains that had lost the transposon insertion. The wild-type P.
multocida strain VP161 is a highly virulent organism, with
fewer than 50 bacteria causing fowl cholera in chickens (44).
Our observations measured the transposon excision rate from
AL251 cells at 1% after the first 10 generations (overnight in
vitro growth), rising to 4% after 58 generations (data not
shown). This rate of excision would result in the generation
and selection of wild-type revertants in chickens at a rate
sufficient to cause lethal fowl cholera infection during the
FIG. 5. Proposed structures of inner core LPS of P. multocida from
parent strain VP161 (a) and mutant strain AL251 (b), where R is the
OS chain extension beyond Glc. Based on negative-ion CE-MS data
shown in Table 3, extension of the mutant LPS molecule to include the
structures shown in parentheses occurs at only low frequency (less than
4%).
TABLE 4. 1H-NMR chemical shifts for the Hep II and Hep III residues from the core OS derived from strains of P. multocida VP161
(parent) and AL251 (mutant)a
Strain and
Hep
Chemical shift NOEsc
H-1 H-2 H-3 H-4 H-5 H-6 H-7 Inter Intra
VP161
Hep II 5.76 4.17 3.85 3.83 3.60 4.05 3.76 5.11 Hep III H-1 4.17 H-2
3.65 4.04 Hep I H-3
Hep II 5.70 4.19 3.86 3.84 3.55 4.05 3.76 5.14 Hep III H-1 4.19 H-2
3.65 3.96 Hep I H-3
Hep III 5.14 4.02 3.87 3.83 3.78 4.05 3.77 5.70 Hep II H-1 4.02 H-2
3.65 4.19 Hep II H-2
Hep III 5.11 4.01 3.87 3.83 3.78 4.05 3.77 5.76 Hep II H-1 4.01 H-2
3.65 4.17 Hep II H-2
AL251
Hep II 5.22 4.07 3.89 3.72 NDb ND ND 4.03 Hep I H-3
Hep II 5.17 4.06 3.88 3.65 ND ND ND ND
a Recorded at 25°C in D2O. Chemical shifts are referenced to internal acetone at 2.225 ppm. Two resonances were observed for each residue due to heterogeneity
of the KDO molecule following core hydrolysis.
b ND, not determined.
c Inter, between residues; intra, with residues.
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course of the trial. We therefore conclude that a stable inac-
tivation of waaQPM would result in a P. multocida strain inca-
pable of causing fowl cholera. However, a reliable method of
constructing defined mutants in P. multocida has not yet been
established.
Analysis of the P. multocida VP161 wild-type LPS indicated
a “rough” LPS, similar to the LPS or lipooligosaccharide iso-
lated from gram-negative mucosal pathogens such as Hae-
mophilus influenzae, H. ducreyi, Neisseria meningitidis, and N.
gonorrhoeae, with only a short nonrepeating polysaccharide
unit attached to the lipid A (15). The inner-core structure of P.
multocida LPS is similar to that described for H. influenzae,
Mannheimia haemolytica, and H. ducreyi, with a triheptose unit
linked via a KDO residue to lipid A (Fig. 4) (8, 28, 30). In the
AL251 mutant, inactivation of waaQPM resulted in the expres-
sion of a highly truncated LPS that lacked the third heptose
molecule (Hep III) in the inner-core region (Fig. 2b). The most
abundant glycoforms of LPS in the mutant also lacked all
sugars distal to the first heptose, suggesting that the inactiva-
tion of waaQPM prevented further sugar additions (Table 3). It
is therefore probable that conformational changes in the LPS
intermediates due to the lack of the third heptose largely
prevented the action of subsequent transferases.
The loss of a full-length LPS molecule clearly affects the
ability of the mutant AL251 to grow in mice and to cause
disease in chickens. The specific reasons for this attenuation
are not clear. However, in wild-type P. multocida VP161 LPS,
two PCho groups were identified, while the AL251 mutant
contained only a single PCho group in a very minor glycoform
(Table 3). The presence of more than one PCho residue in the
VP161 LPS is unusual; bacteria with PCho-decorated LPS
usually have only a single residue attached, although the posi-
tion of attachment onto the LPS structure varies. Only one
other bacterium, a nontypeable H. influenzae strain, is known
to have two PCho residues attached to the LPS (M. K. Land-
erholm et al., unpublished observations). Interestingly, there
are no PCho groups on the LPS of the serotype A turkey
isolate, PM70 (A. D. Cox, unpublished observations), and this
strain is not virulent for chickens (I. W. Wilkie, unpublished
observations).
PCho groups are frequently attached to various bacterial
structures on the surface of mucosal pathogens such as H.
influenzae, Actinobacillus actinomycetemcomitans, Streptococ-
cus pneumoniae, and Neisseria spp and play a key role in ad-
hesion to and invasion of epithelial and endothelial host cells
by binding to the platelet-activating receptor (10, 36–38). Non-
typeable H. influenzae that has PCho-positive glycoforms of
LPS can attach to and invade human bronchial epithelial cells
via a series of signaling events (38, 39). However, in both H.
influenzae and Neisseria spp., although expression of PCho on
LPS was required for adhesion to and invasion of human
epithelial cells, its presence reduced survival in some host
niches, since strains expressing PCho were more serum sensi-
tive, mediated by binding of PCho to C-reactive protein and
subsequent activation of the complement system (37, 41). In-
terestingly, our studies have demonstrated that the LPS mu-
tant AL251 is still highly resistant to the bactericidal action of
complement in chicken serum, indicating that a completely
wild-type LPS structure is not required for the bacteria to have
full serum resistance. This is not surprising, since the waaQPM
mutant is still encapsulated and the hyaluronic acid capsule of
P. multocida serotype A strains confers serum resistance (6).
Although it is likely that the observed attenuation of the
waaQPM mutant was due directly to the truncated LPS, we
cannot completely exclude the possibility that pleiotropic ef-
fects, such as changes to the outer membrane structure, may
play a role. However, a similar E. coli LPS mutant retained
near-wild-type levels of outer membrane stability, as assessed
by sensitivity to SDS and novobiocin (45).
In conclusion, we have characterized a P. multocida waaQPM
mutant that expresses a severely truncated LPS. We have de-
termined the inner-core structure for both the wild-type P.
multocida LPS molecule and the waaQPM mutant molecule
and demonstrated that a functional waaQPM gene is required
for the addition of the third heptose residue to the inner core
of the LPS. Thus, the waaQPM product has been identified as
a heptosyltransferase III, and through virulence trials we have
demonstrated that its activity is required for bacterial virulence
in chickens, the natural host for this P. multocida strain. The
inactivation of waaQPM leads to the complete absence of the
third heptose in the inner core and, as a result, to the fully
wild-type glycoforms. The majority of glycoforms identified
from the mutant LPS lack PCho residues that in LPS of other
gram-negative mucosal pathogens play a key role in bacterial
virulence. Future work will focus on identifying the specific
residues present on the LPS that are required for bacterial
virulence.
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